Cisplatin: A phase II evaluation in previously untreated patients with soft tissue sarcomas Journal Article
| Authors: | Sordillo, P. P.; Magill, G. B.; Brenner, J.; Cheng, E. W.; Dosik, M.; Yagoda, A. |
| Article Title: | Cisplatin: A phase II evaluation in previously untreated patients with soft tissue sarcomas |
| Abstract: | A Phase II trial of moderately high‐dose cisplatin (120 mg/m2 with mannitol diuresis) was conducted in 26 previously untreated patients with soft tissue sarcomas. One partial response (major response rate, 4%) and two minor responses were seen. Severe nausea and vomiting and transient increases in the serum creatinine level were the most common side effects of treatment. Cisplatin has minimal activity as a single agent in patients with soft tissue sarcoma. Cancer 59:884‐886, 1987. Copyright © 1987 American Cancer Society |
| Keywords: | adult; cancer chemotherapy; clinical article; aged; middle aged; cisplatin; drug efficacy; side effect; chemotherapy; nephrotoxicity; phase 2 clinical trial; nausea; vomiting; sarcoma; soft tissue; gastrointestinal toxicity; kidney; soft tissue sarcoma; drug therapy; mannitol; adverse drug reaction; therapy; intravenous drug administration; drug evaluation; intoxication; value; diuresis; humans; human; male; female; priority journal |
| Journal Title: | Cancer |
| Volume: | 59 |
| Issue: | 5 |
| ISSN: | 0008-543X |
| Publisher: | Wiley Blackwell |
| Date Published: | 1987-03-01 |
| Start Page: | 884 |
| End Page: | 886 |
| Language: | English |
| DOI: | 10.1002/1097-0142(19870301)59:5<884::Aid-cncr2820590504>3.0.Co;2-k |
| PUBMED: | 3815267 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 5 February 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work